Cory berkland.

Oct 11, 2021 · Cory J. Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, 1530 West 15th Street, Lawrence, KS, 66045 USA. Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, KS, 66047 USA. E-mail: [email protected] Search for more papers by this author

Cory berkland. Things To Know About Cory berkland.

Sep 17, 2020 · As part of the BME seminar series, join us for this presentation by Cory Berkland, Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. This seminar will be virtual. Register for this event by going here. Abstract: Effective delivery of drugs to therapeutic targets requires an ... Teruna, and Berkland Cory* Department of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, Lawrence, Kansas, 66047 ... Kansas 66047 Phone: (785) 864-1455 Fax: (785) 864-1454 [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our ...Name: CORY BERKLAND Phone: (785) 864-1455 Email: [email protected]. Business Contact. Name: CORY BERKLAND Phone: (785) 764-0125 Email: [email protected]. Research Institution. N/A . Abstract. PROJECT SUMMARY/ABSTRACT Hereditary Hemochromatosis (HH) is one of the most common genetic disorders in the United …Cory J Berkland from Lawrence, KS. Age: 46 years old. Also known as: Mr Cory Berkland, Cory Berkland, Mr Cory J Berkland. View Full Report . Mobile number (785) 764-0127 . Landline number (785) 838-3023 . Email addresses. [email protected]. [email protected] . Relatives. Jodi Berkland .

Cory Berkland. Drugs that can be used to diffuse iron overload exist, he said, but they are absorbed throughout the body, have "nasty" side effects and are really designed for other blood ...Cory Berkland. Drugs that can be used to diffuse iron overload exist, he said, but they are absorbed throughout the body, have "nasty" side effects and are really designed for other blood ...

Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile .

The average moduli of the scaffolds, determined from the stress–strain plots using the end of the initial linear regions before the onset of the nonlinear region (the rationale for this will explained later), ranged from 71 to 196 kPa (Fig. 3), which may be suitable for cartilage tissue engineering applications.A higher intrinsic viscosity of the …Acute B-Cell Inhibition by Soluble Antigen Arrays is Valency-Dependent and Predicts Immunomodulation in Splenocytes J. Daniel Griffin1, Martin A. Leon2, Jean R. Salash3, Michael Shao4, Brittany L. Hartwell1, Chad J. Pickens3, Joshua O. Sestak3, Cory Berkland1,3,4 1Bioengineering Graduate Program, University of Kansas, Lawrence, KS 2Department of Chemistry, University of Kansas, Lawrence, KSJun Yang, 1, 2 Sheng-Xue Xie, 3 Yiling Huang, 1, 4 Min Ling, 1 Jihong Liu, 2 Yali Ran, 1 Yanlin Wang, 4 J Brantley Thrasher, 1 Cory Berkland, 3 and Benyi Li *, 1, 4 ... C Berkland would like to acknowledge supports for the project from the Coulter Foundation, the NIH (AR054035) and the NSF (0966614).Modeling release of small molecules from degradable microspheres is important to the design of controlled-release drug delivery systems. Release of small molecules from poly(d,l-lactide-co-glycolide) (PLG) particles is often controlled by diffusion of the drug through the polymer and by polymer degradation.By Akihisa Nonoyama, Ph.D., Nathan Dormer, Ph.D., and Cory Berkland, Ph.D., Adare Pharma Solutions Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. An alternate presentation of the drug in the form of controlled release microspheres would ...

Cory Berkland. Pharmaceutical Chemistry University of Kansas, Lawrence, Kansas, United States. Chemical and Petroleum Engineering University of Kansas, Lawrence, Kansas, United States. Search for more papers by this author. Bradley Sullivan, Bradley Sullivan.

BME Faculty Directory. Cardiovascular Engineering. Orthopedic Engineering. Women's Health Technologies.

Cory Berkland, PhD, is the Solon E Summerfield Distinguished Professor at the University of Kansas, US. He is a co-founder and was Chief Scientific Officer of Orbis Biosciences (now Adare Pharmaceuticals) amongst other companies including Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Professor Berkland has a PhD in Chemical and ...Vaccine-like Controlled-Release Delivery of an Immunomodulating Peptide to Treat Experimental Autoimmune Encephalomyelitis Barlas Büyüktimkin1, Qun Wang2, Paul Kiptoo1, John M. Stewart1, Cory Berkland1,2, and Teruna J. Siahaan1,* 1Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KSpH-sensitive triblock copolymers for efficient siRNA encapsulation and delivery†. Check for updates. Jian Qiana and Cory Berkland*ab. Author affiliations.The goal of this work was to fabricate uniform double-walled microspheres comprising PCPH cores and PLG shells designated PLG (PCPH), as well as PLG cores and PCPH shells designated PCPH (PLG), each exhibiting a controllable shell thickness, as a means to potentially achieve advanced drug delivery profiles. Initially, PCPH (15% wt/vol in DCM ...Cory Berkland Zahra Mohammadi Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) University of Kansas Original Assignee University of Kansas Priority date (The priority date is an assumption and is not a legal conclusion.Apr 6, 2017 · Patent number: 10398649. Abstract: Particles for delivery of active ingredients formed from an active ingredient and a hydrophobic matrix, as well as methods for making such particles. Type: Grant. Filed: October 16, 2017. Date of Patent: September 3, 2019. Assignee: Orbis Biosciences, Inc. Inventors: Cory Berkland, Milind Singh. Corresponding Author. Cory Berkland [email protected] Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66047 USA. E-mail: [email protected]; [email protected] Search for more papers by this author

Amir Fakhari1 and Cory Berkland1,2,3,* 1Bioengineering Graduate Program, University of Kansas 2Department of Pharmaceutical Chemistry, School of Pharmacy, ... [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourTeruna, and Berkland Cory* Department of Pharmaceutical Chemistry, School of Pharmacy, The University of Kansas, Lawrence, Kansas, 66047 ... Kansas 66047 Phone: (785) 864-1455 Fax: (785) 864-1454 [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our ...Cory Berkland. [email protected]; Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047===Search for more papers by this authorCory Berkland. Corresponding Author. E-mail address: [email protected]. Department of Chemical and Petroleum Engineering, The University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047.Supang Khondee, Tatyana Yakovleva, Cory Berkland. First published: 04 August 2010. https://doi.org/10.1002/app.32460. Citations: 2. Read the full text. PDF. …Dr. Cory Berkland is Chairman of the Board, President, CEO, and Co-Founder of Bond Biosciences. He is Distinguished Professor at The University of Kansas and has extensive experience founding, growing, and exiting pharmaceutical companies including Orbis Biosciences and Savara Pharmaceuticals.Singkome Tima, Songyot Anuchapreeda, Chadarat Ampasavate, Cory Berkland, Siriporn Okonogi. Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. European Journal of Pharmaceutics and Biopharmaceutics 2017, 114, 57-68. DOI: 10.1016/j.ejpb.2016.12.032.

Conflict of interest C. Berkland has a patent (US 20110287547 A1) on Ca-TAT peptides. These studies were not solicited or funded by any pharmaceutical company. ... Cory Berkland, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS …Cory Berkland. Pharmaceutical Chemistry University of Kansas, Lawrence, Kansas, United States. Chemical and Petroleum Engineering University of Kansas, Lawrence, Kansas, United States. Search for more papers by this author. Bradley Sullivan, Bradley Sullivan.

Cory Plock was the best professor I had while completing a MS in Computer Science at NYU. He introduced programming languages with a tremendous amount of expertise and compassion. His assignments and exams were very challenging, yet he consistently went above and beyond to provide support, giving guidance and detailed feedback. Thank you, Cory!Cory Berkland. [email protected]; Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047Search for more papers by this authorGage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7.Cory Berkland Mario Rivera Kate ESHELMAN Jian QIAN Nashwa EL-GENDY Original Assignee The University Of Kansas Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2014-10-10 Filing date 2015-10-08 …Jun 12, 2017 · Brittany L Hartwell 1 , Chad J Pickens 2 , Martin Leon 3 , Cory Berkland 1 2 4 Affiliations 1 Bioengineering Graduate Program, University of Kansas 1520 West 15th Street, Lawrence, Kansas 66045, United States. pH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.Biography —. Distinguished Professor of Chemical and Petroleum Engineering and Pharmaceutical Chemistry. Singkome Tima; Siriporn Okonogi; Chadarat Ampasavate; Chad Pickens; Cory Berkland; Songyot Anuchapreeda: 18-Jul-2015: HPMA-based polymeric micelles for curcumin solubilization and inhibition of cancer cell growth: Ornchuma Naksuriya; Yang Shi; Cornelus F. Van Nostrum; Songyot Anuchapreeda; Wim E. Hennink; Siriporn OkonogiDeanna Diaz, Emporia, is a sophomore at KU studying chemical engineering. Diaz is in the IMSD program and mentored by Cory Berkland, professor of pharmaceutical chemistry. Marissa Duckett, Oklahoma City, is a sophomore at KU studying microbiology.1. Introduction. Injectable scaffolds have received attention due to their potential for avoiding the invasive surgery typically required for tissue implantation. 1 From a clinical perspective, the use of injectable materials is an attractive alternative to surgery as it reduces the risk of infection, scar formation, patient discomfort and the cost of treatment. 2 Injectable scaffolds may be ...

In recent history, through the merger of engineering and biological sciences, biotechnology has pressed toward improving methods for regenerating tissues, developing biosensors, and effectively delivering therapeutic agents.

Cory Berkland, Chief Executive Officer of Bond, commented that "we are highly encouraged by these results, which demonstrate the mechanism and clinical activity of BBI-001 after just a single dose.

Development of budesonide nanocluster dry powder aerosols: Processing Development of budesonide nanocluster dry powder aerosols: Processing El‐Gendy, Nashwa; Selvam, Parthiban; Soni, Pravin; Berkland, Cory 2012-09-01 00:00:00 Aerosolized medicine is one of the fastest growing areas in the pharmaceutical industry. Dry powder aerosols of pharmaceutical compounds are particularly attractive for ...Cory Berkland. Chemical & Petroleum Engineering, 1530 West 15th Street, University of Kansas, Lawrence, Kansas 66045-7609. Department of Pharmaceutical Chemistry, 2095 Constant Ave, University of Kansas, Lawrence, Kansas 66045-7609. Search for more papers by this authorCory Berkland spun Austin, Texas-based Savara Inc. out of his University of Kansas lab in 2007 to develop aerosolized drug therapies. It's the first company wpH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047.BERKLAND LAB TEAM. Our group is made up of extraordinary people that are well versed in the synthesis and characterization of polymers and colloids, validating and quantifying conjugation reactions, and formulating these materials for in vivo applications. They have developed novel approaches for controlling the physicochemical properties of ...About. My PhD work in Bioengineering at the University of Kansas was performed under the advisement of Dr. Cory Berkland. My research entails the fabrication and validation of a high throughput ...Cory Berkland Diabetes is a set of diseases characterized by defects in insulin utilization, either through autoimmune destruction of insulin-producing cells (Type I) or insulin resistance (Type II).BERKLAND CORY. Author information. Affiliations. All authors. 1. KIM KYEKYOON Patent: Reexamination Certificate Second Reexamination - United States Application: US20030624029 on 21 Jul 2003 Publication: 21 Jul 2003 PAT: US7368130 . Patent. Share this article ...Chittasupho C, Shannon L, Siahaan TJ, Vines CM, Berkland C. Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response. ACS Nano. 2011; 5 (3):1693–702. doi: 10.1021/nn102159g. [Europe PMC free article] [Google Scholar]pH-sensitive triblock copolymers for efficient siRNA encapsulation and delivery†. Check for updates. Jian Qiana and Cory Berkland*ab. Author affiliations.Barlas Büyüktimkin, 1 Qun Wang, 2 Paul Kiptoo, 1 John M. Stewart, 1 Cory Berkland, 1, 2 and Teruna J. Siahaan 1, * Barlas Büyüktimkin 1 Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, KS

Prof. Cory Berkland (Chair) Prof. Marylee Southard Prof. Stevin Gehrke Date Approved: iii Abstract: Magnetic nanoparticles that display high saturation magnetization and high magnetic susceptibility with a size less than 200 nm are of great interest for medical applications. Investigations of magnetic nanoparticles have beenBrittany L. Hartwell, 1 Chad J. Pickens, 2 Martin Leon, 3 Laura Northrup, 2 Matthew Christopher, 2 J. Daniel Griffin, 1 Francisco Martinez-Becerra, 4 and Cory Berkland 1, 2, 5, * Brittany L. Hartwell 1 Bioengineering Graduate Program, University of Kansas 1520 West 15 th Street, Lawrence, KS 66045, USABrad Spitz, Nathan Dormer & Cory Berkland are part of Orbis Biosciences leadership, Maria Stecklein Flynn is the CEO.Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh ... Berkland: Bajoria, Sakashi: Volkin: Barreto, Layla: Volkin: Basra, Anil: Hageman:Instagram:https://instagram. what is dsw in social worklily mascotwyze camera solid yellow lightspca spotsylvania va "Soft" Calcium Crosslinks Enable Highly Efficient Gene Transfection Using TAT Peptide Abdulgader Baoum1, Sheng-Xue Xie1, Amir Fakhari2, and Cory Berkland1,3,4 1Department of Pharmaceutical Chemistry, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas 66047, USA 2Department of Bioengineering, The University of Kansas, 2030 Becker Drive, Lawrence, Kansas origin of persimmon fruitlake havasu theaters movie times A Kaviratna and P Dhar would like to acknowledge support from the Jay Award from the Higuchi Biosciences Center and the NIH (Award number: P20GM103638). N El-Gendy and C Berkland would like to acknowledge support from the Coulter Foundation and the NSF (Award number: CHE 0966614). what time does kansas play football today Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39(11):2275-2289. doi: 10.1038/s41388-019-1141-7.Brittany L. Hartwell, Chad J. Pickens, Martin Leon, and Cory Berkland . Multivalent Soluble Antigen Arrays Exhibit High Avidity Binding and Modulation of B Cell Receptor-Mediated Signaling to Drive Efficacy against Experimental Autoimmune Encephalomyelitis. Biomacromolecules 2017, 18 (6) , 1893-1907. DOI: 10.1021/acs.biomac.7b00335. ...About KU Pharmaceutical Chemistry. The collaborative research environment within the Department of Pharmaceutical Chemistry, and with other departments at KU, exposes students to a wide array of modern research in the pharmaceutical sciences, invaluable for a successful career in the chosen field. Our large faculty with diversified interests ...